Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Network Analysis of Gut Microbiome and Metabolome to Discover Microbiota-Linked Biomarkers in Patients Affected by Non-Small Cell Lung Cancer
Pamela Vernocchi, Tommaso Gili, Federica Conte, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8730-8730
Open Access | Times Cited: 110

Showing 1-25 of 110 citing articles:

Next-generation probiotics – do they open new therapeutic strategies for cancer patients?
Karolina Kaźmierczak-Siedlecka, Karolina Skonieczna‐Żydecka, Ted R. Hupp, et al.
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 80
Gut microbiota: A new insight into lung diseases
Peijun Ma, Mengmeng Wang, Yun Wang
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113810-113810
Open Access | Times Cited: 79
Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target
Mengwei Zhang, Jinkai Liu, Qiang Xia
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 47
Role of Akkermansia in Human Diseases: From Causation to Therapeutic Properties
Antonio Pellegrino, Gaetano Coppola, Francesco Santopaolo, et al.
Nutrients (2023) Vol. 15, Iss. 8, pp. 1815-1815
Open Access | Times Cited: 42
Critical role of the gut microbiota in immune responses and cancer immunotherapy
Ze-Hua Li, Weixi Xiong, Liang Zhu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 31
The Role of Gut Microbiota in Lung Cancer: From Carcinogenesis to Immunotherapy
Xiangjun Liu, Ye Cheng, Dan Zang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 77
Networks and Graphs Discovery in Metabolomics Data Analysis and Interpretation
Adam Amara, Clément Frainay, Fabien Jourdan, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 56
Akkermansia supplementation reverses the tumor-promoting effect of the fecal microbiota transplantation in ovarian cancer
Zizhuo Wang, Xu Qin, Dianxing Hu, et al.
Cell Reports (2022) Vol. 41, Iss. 13, pp. 111890-111890
Open Access | Times Cited: 45
The Impact of Food Additives on the Abundance and Composition of Gut Microbiota
Xuewei Zhou, Kaina Qiao, Huimin Wu, et al.
Molecules (2023) Vol. 28, Iss. 2, pp. 631-631
Open Access | Times Cited: 33
The hindgut microbiome contributes to host oxidative stress in postpartum dairy cows by affecting glutathione synthesis process
Fengfei Gu, Senlin Zhu, Jinxiu Hou, et al.
Microbiome (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 29
The impact of the gut microbiome on tumor immunotherapy: from mechanism to application strategies
Ciliang Guo, Lingkai Kong, Lingjun Xiao, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 23
A new strategy for immunotherapy of microsatellite‐stable (MSS)‐type advanced colorectal cancer: Multi‐pathway combination therapy with PD‐1/PD‐L1 inhibitors
Lingli Cai, Anqi Chen, Dong Tang
Immunology (2024) Vol. 173, Iss. 2, pp. 209-226
Open Access | Times Cited: 13
Gut microbiota and its metabolites in non-small cell lung cancer and brain metastasis: from alteration to potential microbial markers and drug targets
Haixiao Jiang, Wei Zeng, Xiaoli Zhang, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 13
Open Access | Times Cited: 11
Gut microbiota and dietary intervention: affecting immunotherapy efficacy in non–small cell lung cancer
Yu Xin, Chenguang Liu, Dan Zang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Gut microbial metabolites in lung cancer development and immunotherapy: Novel insights into gut-lung axis
Xinpei Li, Shijie Shang, Meng Wu, et al.
Cancer Letters (2024) Vol. 598, pp. 217096-217096
Closed Access | Times Cited: 9
Gut-Lung Microbiota in Chronic Pulmonary Diseases: Evolution, Pathogenesis, and Therapeutics
Chang Yi Shi, Chen-Huan Yu, Wen Yu, et al.
Canadian Journal of Infectious Diseases and Medical Microbiology (2021) Vol. 2021, pp. 1-8
Open Access | Times Cited: 43
Native and Engineered Probiotics: Promising Agents against Related Systemic and Intestinal Diseases
Haokun Shen, Zitong Zhao, Zengjue Zhao, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 594-594
Open Access | Times Cited: 33
A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer
Haoyu Wang, Jingchun Liu, Yang Jiang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 31
Health and Disease: Akkermansia muciniphila , the Shining Star of the Gut Flora
Chen Xue, Ganglei Li, Xinyu Gu, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 21
Akkermansia muciniphila: A potential target and pending issues for oncotherapy
Xu Zhao, Juanjuan Zhao, Dongmei Li, et al.
Pharmacological Research (2023) Vol. 196, pp. 106916-106916
Open Access | Times Cited: 20
Gut microbiota and its metabolic products in acute respiratory distress syndrome
Dongwei Zhang, Jiali Lu, Bi-Ying Dong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Modulation of the Gut Microbiota in Memory Impairment and Alzheimer’s Disease via the Inhibition of the Parasympathetic Nervous System
Sunmin Park, Xuangao Wu
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13574-13574
Open Access | Times Cited: 26
The lung, the niche, and the microbe: Exploring the lung microbiome in cancer and immunity
Mai Anh Huynh, Meredith J. Crane, A. M. Jamieson
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 14
Gut Microbiota Are a Novel Source of Biomarkers for Immunotherapy in Non-Small-Cell Lung Cancer (NSCLC)
Teresa Del Giudice, Nicoletta Staropoli, Pierfrancesco Tassone, et al.
Cancers (2024) Vol. 16, Iss. 10, pp. 1806-1806
Open Access | Times Cited: 5
Proline isomerization modulates the bacterial IsdB/hemoglobin interaction: an atomic force spectroscopy study
Francesca Pancrazi, Omar De Bei, Francesco Lavecchia di Tocco, et al.
Discover Nano (2025) Vol. 20, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top